The DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.
The role of dopamine in huntington's disease
Open accessAbstract
Alterations in dopamine (DA) neurotransmission in Parkinson’s disease are well-known and widely studied. Much less is known about DA changes that accompany and underlie some of the symptoms of Huntington’s disease (HD), a dominant inherited neurodegenerative disorder characterized by chorea, cognitive deficits and psychiatric disturbances. The cause is an expansion in CAG (glutamine) repeats in the HTT gene. The principal histopathology of HD is the loss of medium-sized spiny neurons (MSNs) and, to a lesser degree, neuronal loss in cerebral cortex, thalamus, hippocampus and hypothalamus. Neurochemical, electrophysiological and behavioral studies in HD patients and genetic mouse models suggest biphasic changes in DA neurotransmission. In the early stages DA neurotransmission is increased leading to hyperkinetic movements that can be alleviated by depleting DA stores. In contrast, in the late stages DA deficits produce hypokinesia that can be treated by increasing DA function. Alterations in DA neurotransmission affect glutamate receptor modulation and could contribute to excitotoxicity. The mechanisms of DA dysfunction, in particular the increased DA tone in the early stages of the disease, are presently unknown but may include initial upregulation of DA neuron activity caused by the genetic mutation, reduced inhibition resulting from striatal MSN loss, increased excitation from cortical inputs, and DA autoreceptor dysfunction. Targeting both DA and glutamate receptor dysfunction could be the best strategy to treat HD symptoms.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Tetrabenazine as antichorea therapy in Huntington disease: A randomized controlled trial
Huntington Study Group (2006) · Neurology · doi:10.1212/01.wnl.0000198586.85250.13 · Cited by 471
Murphy, K. P. S. J., Carter, R. J., Lione, L. A., Mangiarini, L., Mahal, A., Bates, G. P., Dunnett, S. B., & Morton, A. J. (2000) · The Journal of Neuroscience · doi:10.1523/jneurosci.20-13-05115.2000 · Cited by 398
Self-citationMurase, S., Grenhoff, J., Chouvet, G., Gonon, F. G., & Svensson, T. H. (1993) · Neuroscience Letters · doi:10.1016/0304-3940(93)90641-w · Cited by 387
Prefrontal neurons in networks of executive memory
Fuster, J. M. (2000) · Brain Research Bulletin · doi:10.1016/s0361-9230(99)00258-0 · Cited by 166
Striatal parvalbuminergic neurons are lost in Huntington's disease: implications for dystonia
Reiner, A., Shelby, E., Wang, H., DeMarch, Z., Deng, Y., Guley, N. H., Hogg, V., Roxburgh, R., Tippett, L. J., Waldvogel, H. J., et al. (2013) · Movement Disorders · doi:10.1002/mds.25624 · Cited by 102
Cited by
Dopamine: Functions, Signaling, and Association with Neurological Diseases
Klein, M. O., Battagello, D. S., Cardoso, A. R., Hauser, D. N., Bittencourt, J. C., & Correa, R. G. (2019) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-018-0632-3 · Cited by 1,073
Dopamine: The Neuromodulator of Long-Term Synaptic Plasticity, Reward and Movement Control
Speranza, L., di Porzio, U., Viggiano, D., de Donato, A., & Volpicelli, F. (2021) · Cells · doi:10.3390/cells10040735 · Cited by 415
Depression in neurodegenerative diseases: Common mechanisms and current treatment options
Galts, C. P. C., Bettio, L. E. B., Jewett, D. C., Yang, C. C., Brocardo, P. S., Rodrigues, A. L. S., Thacker, J. S., & Gil-Mohapel, J. (2019) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2019.04.002 · Cited by 269
The Formation and Function of the VTA Dopamine System
Hou, G., Hao, M., Duan, J., & Han, M.-H. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25073875 · Cited by 65
Metadata
- Authors
- Cepeda, C., Murphy, K. P. S., Parent, M., & Levine, M. S.
- Venue
- Progress in Brain Research
- Publisher
- Elsevier
- Published
- 2014
- Volume
- 211
- Pages
- 235-254
- ISSN
- 0079-6123 (ISSN-L)
- OpenAlex
- W1488008685
- Cited by
- 170
- References
- 5
- FWCI
- 9.82
- Type
- book chapter
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: The role of dopamine in huntington's disease. https://app.cochat.ai/papers/10.1016/b978-0-444-63425-2.00010-6
- The paper
- Cepeda, C., Murphy, K. P. S., Parent, M., & Levine, M. S. (2014). The role of dopamine in huntington's disease. Progress in Brain Research. https://doi.org/10.1016/b978-0-444-63425-2.00010-6
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.